JANUARY EFFECT: UP TO 843% ANNUALIZED GAIN

Twitter
LinkedIn
Facebook

By Nigam Arora & Dr. Natasha Arora

Signal(s) to enter, add, reduce, exit, hold or change.

Here are the key points on January Effect trades:

  • There were five fills.
  • Four trades are nicely profitable.  The fifth trade is at a slight profit to break even, depending upon how it was bought.
  • Since gains have occurred over a short period of time, annualized gains become rather large.
  • The maximum annualized gain on a position is 843%.

What To Do Now

These stocks have a lot of room to run.  If the market rallies, four of the stocks listed below can easily double or even triple from here.  The fifth, GTLS, can gain 30% – 40% from here.  On the other hand, these are long duration stocks.  Please listen to the podcast titled “Be Careful With Popular Long Duration Stocks.”  If the market starts viciously selling long duration stocks again, all the gains will be quickly lost.

What to do now depends on your personal preference due to high market volatility.  Here are helpful guidelines.

Desktop Metal

DM is a 3D printing company producing high grade advanced materials.

The gain on DM is 46.2%.  This translates to 843% annualized gain.  DM closed at $1.71.

Consider taking partial or full profits based on personal preference. If taking partial profits, move the stop to 🔒 (To see the locked content, please take a 30 day free trial) on the remaining quantity.

Bionano Genomics

BNGO provides products and services for  thorough analysis of the genome.

The gain on BNGO is 31.9%.  This translates to 647% annualized gain.  BNGO closed at $1.82.

Consider taking partial or full profits based on personal preference. If taking partial profits, move the stop to 🔒 on the remaining quantity.

Aurora Innovation

AUR is developing self-driving technology.

The gain on AUR is 17.1%.  This translates to 347% annualized gain.  AUR closed at $1.30.

Consider taking partial or full profits based on personal preference. If taking partial profits, move the stop to 🔒 on the remaining quantity.

Chart Industries

GTLS makes, sells, and services equipment for the liquid gas supply chain. GTLS equipment is also being used for the new hydrogen economy.

The gain on GTLS is 15%.  This translates to 166% annualized gain.  GTLS closed at $133.71.

Consider taking partial or full profits based on personal preference. If taking partial profits, move the stop to 🔒 on the remaining quantity.

Cano Health

CANO provides online healthcare to seniors. CANO is a buyout target, but there is also the risk of the company running out of cash and filing for bankruptcy. If the company is able to raise adequate cash, it can potentially ultimately be bought out even over $10.

Considering the high risk reward nature of this stock, what to do now entirely comes down to personal preference. One good option to consider is to reduce  the quantity and put a stop on the rest.  However, you need to be aware that if there is a gap down, the stop may not protect you.  The stop zone is 🔒.

To take a free 30-day trial to paid services to gain access to more opportunities, please click here.

This post was just published on ZYX Buy Change Alert.

Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Nigam Arora

Nigam Arora

Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.

Dr. Natasha Arora

Dr. Natasha Arora

Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.

Subscribe to 'Generate Wealth'

Free Forever

More To Explore

30 Day Free Trial

Cancel within 30 days and you owe nothing

When you take a FREE 30 day trial, you get access to powerful techniques used by billionaires and hedge funds to grow richer. You can continue to use these powerful techniques to grow richer even if you cancel your subscription. You come out ahead by subscribing no matter how you look at it.

Do you want to gain an edge in the markets? Join thousands of your fellow investors and money managers to subscribe to Generate Wealth newsletter.

FREE FOREVER

Follow The Most Accurate Stock Market Analysis

Unrivaled Insights
In Bull and Bear Markets

Generate Wealth Newsletter
Free Forever

Generate Wealth Newsletter
Free Forever